Exosome-Mediated Drug Resistance Transfer in Cell Lines
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for preparing drug-resistant cells are inefficient and do not effectively replicate the drug resistance mechanism, particularly in cancer treatment, where genetic mutations are not the primary cause of resistance, and existing drug screening methods lack consistency with clinical results.
Innovation Solution
A method involving the use of exosomes derived from drug-resistant organisms to confer drug resistance on sensitive cells by contact and culture, allowing for the creation of drug-resistant cell lines without genetic mutation introduction, and a kit for screening anticancer drugs using these cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If genetic engineering techniques (CRISPR/Cas 9, GENESIS) are used to prepare drug-resistant cells, then the ease of manufacture is improved, but the reliability deteriorates because genetic mutations do not accurately reflect clinical drug resistance mechanisms
Solution Approach 1:
The patent introduces exosomes as an intermediary substance to transfer drug resistance characteristics from resistant parent cells to sensitive daughter cells. This mediator mechanism allows the transmission of resistance without requiring direct genetic modification of the target cells, thereby maintaining ease of preparation while improving the biological accuracy of the resistance model to reflect true clinical mechanisms
Solution Approach 2:
Instead of directly editing the genome of target cells, the patent uses exosomes to copy and transfer resistance characteristics from parent cells. This copying approach through extracellular vesicles preserves the natural resistance mechanisms observed in clinical settings while avoiding the artifacts introduced by direct genetic engineering
2Reliability
If cells are cultured over a long period to acquire drug resistance, then the reliability of resistance acquisition is improved, but the loss of time increases
Solution Approach 1:
The patent performs preliminary isolation and preparation of exosomes from drug-resistant parent cells before applying them to sensitive daughter cells. This preliminary action concentrates the resistance characteristics in the exosomes, allowing rapid transfer and acquisition of resistance in a shortened culture period without requiring prolonged exposure to the drug
3Productivity
If exosomes from drug-resistant cells are used to confer resistance on sensitive cells, then the productivity is improved, but the device complexity increases due to additional isolation and purification steps
Solution Approach 1:
The patent optimizes parameters such as exosome concentration, cell ratio, and culture conditions to enhance the efficiency of resistance transfer. By carefully controlling these parameters, the process achieves rapid resistance acquisition while managing the complexity of exosome isolation and application steps
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables quick and simple preparation of drug-resistant cells and effective anticancer drug screening, aligning with clinical adaptabilities and providing a novel method for assessing drug resistance and efficacy.
Implementation Method 1
contacting exosomes from a living organism exhibiting drug resistance with cells exhibiting no drug resistance such that drug resistant cells are formed
Data Source
AI summary
A method of producing drug resistant cells including contacting exosomes from a living organism exhibiting drug resistance with cells exhibiting no drug resistance such that drug resistant cells are formed, and culturing the drug resistant cells.